These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 19962348)

  • 1. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.
    Lancaster E; Lai M; Peng X; Hughes E; Constantinescu R; Raizer J; Friedman D; Skeen MB; Grisold W; Kimura A; Ohta K; Iizuka T; Guzman M; Graus F; Moss SJ; Balice-Gordon R; Dalmau J
    Lancet Neurol; 2010 Jan; 9(1):67-76. PubMed ID: 19962348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-mediated cytotoxicity of antibodies to the GABA(B) receptor.
    Batocchi AP; Della Marca G; Frisullo G
    Lancet Neurol; 2010 Apr; 9(4):343; author reply 343-4. PubMed ID: 20298957
    [No Abstract]   [Full Text] [Related]  

  • 3. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.
    Petit-Pedrol M; Armangue T; Peng X; Bataller L; Cellucci T; Davis R; McCracken L; Martinez-Hernandez E; Mason WP; Kruer MC; Ritacco DG; Grisold W; Meaney BF; Alcalá C; Sillevis-Smitt P; Titulaer MJ; Balice-Gordon R; Graus F; Dalmau J
    Lancet Neurol; 2014 Mar; 13(3):276-86. PubMed ID: 24462240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.
    Gultekin SH; Rosenfeld MR; Voltz R; Eichen J; Posner JB; Dalmau J
    Brain; 2000 Jul; 123 ( Pt 7)():1481-94. PubMed ID: 10869059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.
    Lai M; Huijbers MG; Lancaster E; Graus F; Bataller L; Balice-Gordon R; Cowell JK; Dalmau J
    Lancet Neurol; 2010 Aug; 9(8):776-85. PubMed ID: 20580615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical analysis of anti-Ma2-associated encephalitis.
    Dalmau J; Graus F; Villarejo A; Posner JB; Blumenthal D; Thiessen B; Saiz A; Meneses P; Rosenfeld MR
    Brain; 2004 Aug; 127(Pt 8):1831-44. PubMed ID: 15215214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.
    Lai M; Hughes EG; Peng X; Zhou L; Gleichman AJ; Shu H; Matà S; Kremens D; Vitaliani R; Geschwind MD; Bataller L; Kalb RG; Davis R; Graus F; Lynch DR; Balice-Gordon R; Dalmau J
    Ann Neurol; 2009 Apr; 65(4):424-34. PubMed ID: 19338055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations.
    Graus F; Saiz A; Lai M; Bruna J; López F; Sabater L; Blanco Y; Rey MJ; Ribalta T; Dalmau J
    Neurology; 2008 Sep; 71(12):930-6. PubMed ID: 18794496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis.
    Mundiyanapurath S; Jarius S; Probst C; Stöcker W; Wildemann B; Bösel J
    J Neuroimmunol; 2013 Jun; 259(1-2):88-91. PubMed ID: 23628208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: the first pediatric case of γ-aminobutyric acid type B receptor autoimmunity.
    Kruer MC; Hoeftberger R; Lim KY; Coryell JC; Svoboda MD; Woltjer RL; Dalmau J
    JAMA Neurol; 2014 May; 71(5):620-3. PubMed ID: 24590315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis.
    Hansen N; Widman G; Witt JA; Wagner J; Becker AJ; Elger CE; Helmstaedter C
    Epilepsy Behav; 2016 Dec; 65():18-24. PubMed ID: 27855355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders.
    Boronat A; Sabater L; Saiz A; Dalmau J; Graus F
    Neurology; 2011 Mar; 76(9):795-800. PubMed ID: 21357831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis.
    Kim TJ; Lee ST; Shin JW; Moon J; Lim JA; Byun JI; Shin YW; Lee KJ; Jung KH; Kim YS; Park KI; Chu K; Lee SK
    J Neuroimmunol; 2014 May; 270(1-2):45-50. PubMed ID: 24662003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
    Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
    Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune epilepsy in children: case series and proposed guidelines for identification.
    Suleiman J; Brilot F; Lang B; Vincent A; Dale RC
    Epilepsia; 2013 Jun; 54(6):1036-45. PubMed ID: 23551014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GABAB receptor encephalitis associated with combined small cell lung carcinoma.
    Chao CH; Chu CC; Wei YC; Tseng JR; Chang HS
    J Neuroimmunol; 2021 Nov; 360():577705. PubMed ID: 34478989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA-B Receptor Encephalitis Triggered by Enterovirus Encephalitis in a Patient With Small Cell Lung Cancer: A Case Report.
    Kim SH; Kim W
    Neurologist; 2020 Jul; 25(4):106-108. PubMed ID: 32618841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated seizures are a common early feature of paraneoplastic anti-GABA
    Maureille A; Fenouil T; Joubert B; Picard G; Rogemond V; Pinto AL; Thomas L; Ducray F; Quadrio I; Psimaras D; Berzero G; Antoine JC; Desestret V; Honnorat J
    J Neurol; 2019 Jan; 266(1):195-206. PubMed ID: 30460450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
    Irani SR; Bera K; Waters P; Zuliani L; Maxwell S; Zandi MS; Friese MA; Galea I; Kullmann DM; Beeson D; Lang B; Bien CG; Vincent A
    Brain; 2010 Jun; 133(Pt 6):1655-67. PubMed ID: 20511282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.